Literature DB >> 32406037

COVID-19: is fibrosis the killer?

Andrew Leask1.   

Abstract

COVID-19 is a respiratory disease. A recent report in Lancet examined, retrospectively, 137 patients with COVD-19. Patients that died had elevated IL-6 levels and acute respiratory distress syndrome. These data have obvious implications for how to control mortality in COVID-19.

Entities:  

Keywords:  COPD; COVID-19; Fibrosis; IL-6

Year:  2020        PMID： 32406037      PMCID： PMC7220615          DOI： 10.1007/s12079-020-00569-0

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN： 1873-9601            Impact factor:   5.782


  1 in total

1.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321
  1 in total
  4 in total

1.  Welcome to 2021.

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2021-03       Impact factor: 5.782

2.  Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome.

Authors:  Lawrence B Afrin; Leonard B Weinstock; Gerhard J Molderings
Journal:  Int J Infect Dis       Date:  2020-09-10       Impact factor: 3.623

Review 3.  Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-β signalling in COVID-19 survivors.

Authors:  Krishna Murthy P; Karthikeyan Sivashanmugam; Mahesh Kandasamy; Rajasekaran Subbiah; Vilwanathan Ravikumar
Journal:  Life Sci       Date:  2020-12-11       Impact factor: 6.780

Review 4.  A Quick Review on the Multisystem Effects of Prone Position in Acute Respiratory Distress Syndrome (ARDS) Including COVID-19.

Authors:  Janet O Adeola; Shivani Patel; Evelyne N Goné; George Tewfik
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2021-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.